Related Experiment Videos
Sarcoidosis in India: practical issues and difficulties in diagnosis and management
Surinder Kumar Jindal1, Dheeroy Gupta, Ashutash Nath Aggarwal
1Department of Pulmonary Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India. skjindal@i91.net.in
Summary
Diagnosing sarcoidosis is challenging due to its similarity to tuberculosis. Corticosteroids are key for treatment, but steroid-sparing drugs like methotrexate offer alternatives for difficult cases.
Area of Science:
- Pulmonology
- Immunology
- Infectious Diseases
Background:
- Sarcoidosis is an emerging lung disease presenting diagnostic and management challenges.
- Its clinical, radiological, and histopathological similarities to tuberculosis complicate differential diagnosis.
- High prevalence of tuberculosis, including extrapulmonary forms, hinders confident exclusion.
Purpose of the Study:
- To highlight the diagnostic difficulties in differentiating sarcoidosis from tuberculosis.
- To emphasize the importance of accurate diagnosis for appropriate treatment selection.
- To discuss treatment strategies for sarcoidosis, including corticosteroids and steroid-sparing agents.
Main Methods:
- Differential diagnosis based on clinical, radiological, and histopathological features.
- Utilizing tuberculin-anergy as a distinguishing factor between sarcoidosis and tuberculosis.
- Employing bronchoscopic transbronchial lung biopsy for diagnosis (positive in >80% of sarcoidosis cases).
Main Results:
- Tuberculin-anergy is a key differentiator for sarcoidosis versus tuberculosis.
- Transbronchial lung biopsy is a highly sensitive diagnostic tool for sarcoidosis.
- Corticosteroids are the primary treatment for sarcoidosis, but steroid-sparing drugs are effective alternatives.
Conclusions:
- Accurate differentiation of sarcoidosis from tuberculosis is crucial for effective management.
- While corticosteroids are standard, steroid-sparing drugs like methotrexate and azathioprine show promise.
- Low-dose methotrexate is beneficial for refractory sarcoidosis, relapses, or steroid-intolerant patients.